CSI Market
Sign In | Register

Ascendis Pharma A (ASND) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ASND Annual Balance Sheets →
A period-by-period view of the balance sheet from Ascendis Pharma A to Dec 31 2024 helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents689.97
Current Tax Assets Current1.99
Cash & Short-term Investments690.00
Accounts receivable158.29
Inventories337.72
Other Current Assets54.09
Total Current Assets1,242.06
Equipment/Property/Plant Net164.06
Intangible AssetsAnd Goodwill52.76
Total Assets1,458.88
Liabilities
Current Tax Liabilities7.20
Short-term Debt431.48
Other Liabilities, Current572.67
Current Provisions186.36
Total Current Liabilities1,197.72
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI10.78
Other liabilities, Noncurrent432.74
Total Liabilities1,641.24
Stockholders' Equity
Other Equity-182.36
Common Stockholder's Equity-182.36
Total Stockholder's Equity-182.36
Liabilities & Stockholder's Equity1,458.88
4 historic quarters locked

Sign in to unlock the full Ascendis Pharma A balance sheet history.

Sign In Create Free Account

About Ascendis Pharma A s Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 11, 2026
  • Source: asnd-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-046590

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.